Mannkind Corporation (NASDAQ:MNKD)’S Executive Changes Plunges It On Market

Mannkind Corporation

MannKind Corporation (NASDAQ:MNKD) recently announced changes to its executive management ranks, which tumbled the company’s stock in the recent trading sessions. The company announced recently that Dr. Stuart A. Tross shall serve as company’s new Chief People Officer. He has been entrusted with West Coast Facilities, Information Technology and Human Resource obligation. This led to company’s stock falling 0.52%.

Company aims for development

Dr. Stuart A. Tross will report to the CEO, Matthew Pfeffer. Mannkind Corporation said that Tross will work in accelerating the company’s business development. He has been a part of Amgen from 2006 until 2016 and has been serving into different roles there, since then. Dr. Stuart A. Tross has also served as Amgen’s Senior Vice President and also as the Chief Human Resources Officer at the global platform.

Dr. Stuart A. Tross will bring to Mannkind Corporation his Pharma experience from Bristol-Myers Squibb as well. He served in the Bristol-Myers Squibb from 1998 until 2006. Mannkind Corporation can expect extensive management experience from Tross, who comes on board with his biopharmaceutical background.

The company CEO, Matthew Pfeffer said that his experience will be used for facilitating efficient expansion of its Afrezza launch. He shall be used for company’s “strategic initiatives, such as product development and global expansion.”

Afrezza launch is important to Mannkind Corporation

Afrezza launch plays a key role to company since it is marketed to be its “innovative product in an area of unmet patient need.” Dr. Stuart A. Tross will be seen as a paramount person to ensure not just timely launch of this product, but also someone who can add “growth opportunities in the pipeline.”

It will therefore be vital to note in due course of time, regarding how Dr. Stuart A. Tross’ preence in the company is taken by the market.

Though the market did not give a warming welcome to the new executive in the company, but Mannkind Corporation hopes for a successful 2017 start with its key product launch, at the earliest.


Please enter your comment!
Please enter your name here